Sen. Bernie Sanders launches Senate investigation into 'high' pricing of Ozempic, Wegovy
Briefly

The scientists at Novo Nordisk deserve great credit for developing these drugs that have the potential to be a game-changer for millions of Americans struggling with type 2 diabetes and obesity...if the prices for these products are not substantially reduced, they also have the potential to bankrupt Medicare, Medicaid, and our entire health care system.
Sanders is asking Novo Nordisk to answer whether it will "substantially reduce" the prices of the medications as well as to provide information on how much it makes from selling the drugs, how much it spent on research and development and how it determined the prices.
Read at ABC7 San Francisco
[
add
]
[
|
|
]